Comprehensive analysis of natural killer cell-associated markers using MultiOmyx immunofluorescence assay
Single-cell immunoprofiling and spatial analysis of hormone receptor subtypes in HER2+ and HER2low breast tumors using multiplexed immunofluorescence
ctDNA dynamics in early stage node negative non-small cell lung cancers
Evaluation of a tumor informed MRD assay with contrived breast cancer samples
Landscape of known and novel myeloid neoplasia fusions identified by a multimodal comprehensive genomic profiling test in 789 patients
Single-tube NGS profiling allows identification of molecular signature in ALL patients
NGS assay for simultaneous screening of DNA and RNA provides a comprehensive solution guiding clinical management of ALL patients
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial